Insider Transactions in Q2 2022 at Galectin Therapeutics Inc (GALT)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,359
+2.44%
|
$13,359
$1.31 P/Share
|
|
Jun 15
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,780
+2.58%
|
$13,780
$1.29 P/Share
|
|
May 31
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,566
+2.61%
|
$13,566
$1.29 P/Share
|
|
May 19
2022
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect |
5,000
+7.14%
|
$5,000
$1.33 P/Share
|
|
May 13
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,868
+2.54%
|
$12,868
$1.36 P/Share
|
|
Apr 29
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,290
+2.3%
|
$11,290
$1.55 P/Share
|
|
Apr 18
2022
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect |
5,000
+7.69%
|
$5,000
$1.71 P/Share
|
|
Apr 15
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,057
+2.1%
|
$10,057
$1.74 P/Share
|
|
Apr 04
2022
|
Richard A. Zordani Jr. |
BUY
Open market or private purchase
|
Direct |
5,000
+16.9%
|
$5,000
$1.6 P/Share
|